AzTrials
AzTrials

Orbital FracturesNCT01432964

Use of a Low Profile Titanium Mesh in Orbital Reconstruction

An observational study of Orbital Fractures, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In craniofacial trauma, the involvement of orbital structures is noted in up to 40% of cases (Ellis 1985). Post-traumatic orbital deformities caused by incorrect reconstruction of orbital dimensions are severe complications causing enophthalmos, diplopia and visual acuity disturbance. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Orbital Fractures
What is being tested?
Orbital revision surgery
Type of treatment
Surgery or procedure
How many people
27 participants
Where
1 siteSwitzerland
Study dates
Dec 2008to Oct 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patient with facial fractures, treated at the Department of Oral and Maxillofacial Surgery, University Hospital Bern, Bern, Switzerland.

Who may be able to join

  • adult patients (>18 years)
  • presenting a unilateral orbital blow-out or blow-in fracture of ≥ 2.0cm2, causing an actual or expected functional or aesthetical deficit
  • has to be operated within two weeks of trauma

Who cannot join

  • individuals who did not have any vision on the affected side
  • individuals, who, according to ophthalmologists, should not have a surgical treatment
  • patients who were unable to adequately understand written or oral information in German or French

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Department of Oral and Maxillofacial Surgery, Bern University Hospital

    Bern, 3010 Bern

Other trials in Switzerland

About this study

Official title: Low Profile Titanium Mesh in the Use of Orbital Reconstruction

In craniofacial trauma, the involvement of orbital structures is noted in up to 40% of cases (Ellis 1985). Post-traumatic orbital deformities caused by incorrect reconstruction of orbital dimensions are severe complications causing enophthalmos, diplopia and visual acuity disturbance. To prevent such complications, immediate repair of orbital injuries with the restoration of normal anatomy is indicated in orbital floor fractures. With the help of biodegradable implants small and medium-sized defects are easily managed (Büchel 2005, Lieger 2010). In extensive fractures however, only calvarian bone and titanium mesh considered to provide a sufficient support of the orbital content.

Calvarial bone can be difficult to mould and to adapt to the form and size of the orbital lesion. In addition, donor site morbidity cannot be disregarded. Orbital reconstruction mesh on the other hand is always available and easier to apply. There are however important requirements for these meshes, such as biocompatibility, excellent stability, optimal adaptability and patient comfort. Recently, the company Medartis developed a titanium mesh featuring a low profile. In order to regain normal function, normal anatomy has to be re-established. It therefore seemed reasonable to assess an implant, which would facilitate orbital reconstruction without disturbing normal anatomy by its size, profile height or properties.

The purpose of this study was to assess the use and accuracy of the low profile titanium mesh for primary internal orbital reconstruction.

Read the detailed description

Background

Extensive bone loss after orbital trauma requires reconstruction to preserve ocular function and aesthetics. The optimal material for orbital reconstruction remains controversial. Today a multitude of both autogenous and alloplastic materials have been used for orbital reconstruction, including methylmethacrylate, Teflon, silicone, Supramid, Marlex, Silastic, gelatin film, bioactive glas, bone and cartilage (Haug 1999). The use of alloplastic materials has been tempered by complications such as infection, displacement and extrusion, fistula and cyst formation. During the past two decades, autogenous bone grafts have become increasingly popular for orbital reconstruction. Unfortunately, problems with bone grafts can occur and include unpredictable rates of bone resorption and the risk of subsequent dystopia or delayed enophthalmos, donor site complication, time consumption with harvesting and variable graft thickness and irregularities along with difficulty in graft contouring (Park 2001). These problems have revived interest in alloplastic alternatives, particularly in titanium and its alloys (Park 2001). Titanium shows a low infection rate, related in part to its excellent biocompatibility, which manifests as osseointegration. This circumstance is thought to lessen the rate of infection.

During the past decade, different studies have examined a titanium meshes for orbital repair. Plates used in these studies demonstrate a minimum profile height of 0.25mm.

Objective

Assess the use and accuracy of the low profile titanium mesh for primary internal orbital reconstruction

Methods

Clinical assessment prior to operation by a maxillofacial surgeon with regards to bone and soft tissue lesions as well as concomitant injuries. An ophthalmologist then assessed eye lesions and quantified eye mobility (in mm), bulb positioning (Hertel's exophthalmometry, in mm) as well as the field of binocular vision (Goldmann perimetry, in % of the total).

Preoperative 1mm CT-scans were obtained to analyse size and location of the defect as well as extend of muscle entrapment. The fractures were classified according to the scores introduced by Jaquiery(Jaquiery 2007).

Follow up by at 2, 6 and 12 weeks after the operation (assessments see above), including postoperative CT-scan within 12 weeks. Volume analysis of CT comparing the two orbits (OsiriX Medical Image Software (Version 3.7.1, www.osirix-viewer.com).

Being tested
Orbital revision surgery
Keywords
Orbital Fractures, Fracture Fixation, Blow-out Fractures, Surgical Mesh, Titanium, Computer-assisted Image Processing
Medical subject headings
Orbital Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Orbital revision surgeryProcedure or surgery

    Surgical revisions were performed under general anaesthesia. The orbital floor was routinely exposed via a transconjunctival incision. In patients with involvement of the medial wall, a combined transconjunctival-transcaruncular approach was used. Herniated or incarcerated tissue was then complete repositioned. Stable borders around the bony defect in the orbital floor were exposed. The aluminium template was pre-bend and controlled in situ. Type and size of mesh were chosen and adjustments performed, as needed. Following the bending of the titanium mesh according to the template, it was inserted and fixed with 1.5mm screws. Alternatively the mesh could be preformed, using a sterilized skull model to shape and contour it to a normal orbit. Finally the eye bulb mobility was controlled using fine forceps (forced duction test) and the wound closed (Vicryl 5/0 rapid; optional).

Study groups in NCT01432964
Study groupRoleWhat they receive
1Adult patients (>18 years) presenting a unilateral orbital blow-out or blow-in fracture of ≥ 2.0cm2, causing an actual or expected functional or aesthetical deficit.
Receives: Procedure: Orbital revision surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiological Volume analysis of bony orbits (difference in cm3)

    Measured: postoperative, within 12 weeks after operation

Secondary outcomes (3)
  1. Eye motility (in mm)

    Measured: at 12 weeks after the operation

  2. En/Exophthalmos (Hertel Test) (in mm)

    Measured: at 12 weeks after the operation

  3. Diplopia (in %)

    Measured: at 12 weeks after the operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2011 (estimated)
  2. Study startDec 2008
  3. Study completionOct 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01432964
Sponsor's protocol ID
011/09
Other IDs
0709-0050
Status last verified
Sep 2011
First submitted
12 Sep 2011
Last updated
13 Sep 2011
Results posted
No
Data monitoring committee
No

Publications

  • Ellis E 3rd, el-Attar A, Moos KF. An analysis of 2,067 cases of zygomatico-orbital fracture. J Oral Maxillofac Surg. 1985 Jun;43(6):417-28. doi: 10.1016/s0278-2391(85)80049-5.

    PubMed 3858478
  • Buchel P, Rahal A, Seto I, Iizuka T. Reconstruction of orbital floor fracture with polyglactin 910/polydioxanon patch (ethisorb): a retrospective study. J Oral Maxillofac Surg. 2005 May;63(5):646-50. doi: 10.1016/j.joms.2004.11.013.

    PubMed 15883939
  • Lieger O, Schaller B, Zix J, Kellner F, Iizuka T. Repair of orbital floor fractures using bioresorbable poly-L/DL-lactide plates. Arch Facial Plast Surg. 2010 Nov-Dec;12(6):399-404. doi: 10.1001/archfacial.2010.91.

    PubMed 21079117
  • Haug RH, Nuveen E, Bredbenner T. An evaluation of the support provided by common internal orbital reconstruction materials. J Oral Maxillofac Surg. 1999 May;57(5):564-70. doi: 10.1016/s0278-2391(99)90076-9.

    PubMed 10319830
  • Park HS, Kim YK, Yoon CH. Various applications of titanium mesh screen implant to orbital wall fractures. J Craniofac Surg. 2001 Nov;12(6):555-60. doi: 10.1097/00001665-200111000-00010.

    PubMed 11711822
  • Jaquiery C, Aeppli C, Cornelius P, Palmowsky A, Kunz C, Hammer B. Reconstruction of orbital wall defects: critical review of 72 patients. Int J Oral Maxillofac Surg. 2007 Mar;36(3):193-9. doi: 10.1016/j.ijom.2006.11.002. Epub 2007 Jan 22.

    PubMed 17241771

Questions about this trial

What is this clinical trial studying?

An observational study of Orbital Fractures, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Sep 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiological Volume analysis of bony orbits (difference in cm3) (time frame: postoperative, within 12 weeks after operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01432964, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in